Y Intercept Hong Kong Ltd Purchases 8,877 Shares of Cardinal Health, Inc. $CAH

Y Intercept Hong Kong Ltd increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 50.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 26,613 shares of the company’s stock after purchasing an additional 8,877 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Cardinal Health were worth $4,177,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. SJS Investment Consulting Inc. boosted its stake in shares of Cardinal Health by 1,363.6% during the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after purchasing an additional 150 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC lifted its holdings in Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares during the period. American Capital Advisory LLC boosted its position in Cardinal Health by 5,200.0% during the 3rd quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after acquiring an additional 208 shares in the last quarter. Finally, Vermillion & White Wealth Management Group LLC increased its holdings in shares of Cardinal Health by 55.0% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 71 shares during the period. Institutional investors own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Leerink Partners set a $240.00 price objective on Cardinal Health in a research report on Tuesday, January 13th. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research report on Tuesday, November 18th. Barclays assumed coverage on shares of Cardinal Health in a research report on Monday, December 8th. They set an “overweight” rating and a $243.00 target price for the company. Finally, Evercore ISI lifted their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a report on Friday, October 31st. Fourteen equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $221.07.

Cardinal Health Stock Up 0.7%

Shares of NYSE:CAH opened at $208.29 on Monday. Cardinal Health, Inc. has a 52-week low of $120.72 and a 52-week high of $215.48. The stock has a market cap of $49.49 billion, a price-to-earnings ratio of 31.42, a PEG ratio of 1.41 and a beta of 0.65. The business has a 50-day moving average price of $205.78 and a 200-day moving average price of $176.35.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same quarter in the prior year, the firm earned $1.88 earnings per share. Cardinal Health’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Investors of record on Friday, January 2nd were issued a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend was Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is 30.77%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.